Tata Motors demerges, Passenger and Commercial Vehicle businesses now separate listed entities

• Tata Motors has formally split into two distinct publicly traded companies, one for its passenger vehicle business (including JLR and EVs) and another for its commercial vehicle operations.
• Shareholders on the record date of October 14, 2025, will receive one share in the new commercial vehicle entity for each Tata Motors share they hold.
• The demerger is designed to unlock value by allowing focused strategies and capital allocation for each segment.

Anant Raj raises ₹1,100 crore to fuel data center expansion

• Realty developer Anant Raj has successfully raised ₹1,100 crore through a Qualified Institutional Placement (QIP).
• The funds are earmarked for the expansion and development of its data center and cloud infrastructure business, a vertical the company projects will generate significant revenue.

Adani Enterprises and Google partner for $15 billion AI data hub in Visakhapatnam

• Google will invest $15 billion over five years to establish a massive 1-gigawatt AI data center campus in Visakhapatnam, its largest such investment outside the US.
• The project is a partnership with Adani Enterprises, which will develop the gigawatt-scale data center operations through its joint venture, AdaniConneX.

Oil India completes major pipeline upgrade and secures long-term gas supply deal

• Oil India has achieved mechanical completion of its upgraded Numaligarh–Siliguri Product Pipeline (NSPL), significantly increasing its transportation capacity to handle higher product flows from the Numaligarh Refinery expansion.
• Separately, the company signed a 15-year Gas Sale and Purchase Agreement with North Eastern Electric Power Corporation (NEEPCO) to continue supplying natural gas to a power station in Assam.

Larsen & Toubro's Power Transmission division secures large Middle East orders

• The power transmission and distribution vertical of Larsen & Toubro has won significant orders for grid infrastructure projects in the Middle East.
• The projects are related to the 400kV super grid interconnection that links the electrical networks of GCC member states.

Coral Laboratories announces ₹30 crore capacity expansion

• Coral Laboratories will invest ₹30 crore to double the production capacity at its Dehradun manufacturing plant.
• The expansion will focus on its ointment manufacturing capacity and is intended to meet rising domestic and international demand.

Advait Energy subsidiary signs MoU for ₹14.5 billion investment in Gujarat

• Advait Greenergy Private Limited, a subsidiary of Advait Energy, has signed a Memorandum of Understanding (MoU) with the Government of Gujarat to potentially invest ₹14.5 billion in two projects.
• The state government will facilitate necessary permissions and clearances for the proposed investments.

Allcargo Logistics receives NCLT approval for business demerger

• Allcargo Logistics has secured approval from the National Company Law Tribunal (NCLT) for its restructuring plan.
• The scheme involves demerging its international supply chain business into a new, separately listed entity, Allcargo Global Limited.

Indian pharmaceutical firms poised to benefit from US Biosecure Act

• The U.S. Senate's passage of the Biosecure Act is expected to benefit Indian pharmaceutical and Contract Development & Manufacturing Organization (CDMO) companies.
• The act restricts U.S. federal agencies from procuring biotech equipment from Chinese companies, potentially redirecting business to Indian players like Divi's Laboratories, Syngene International, and Jubilant Pharmova.

Taj GVK and IHCL deepen partnership with new hotel management agreement

• Taj GVK Hotels and Resorts Ltd. has signed a 20-year management contract with The Indian Hotels Company Limited (IHCL) for an upcoming five-star Taj-branded hotel in Bengaluru.
• This move reinforces the strategic alliance between the two companies and aligns with IHCL's asset-light expansion strategy.

Servotech Renewable Power System wins solar project from Indian Railways

• Servotech Renewable Power System has secured a 2.58 MW on-grid rooftop solar PV project order from the South Eastern Railway's Ranchi division.
• The scope of the order includes design, manufacturing, supply, installation, testing, and commissioning of the solar project across multiple railway sites.

Jain Irrigation Systems plans to raise up to ₹500 crore via QIP

• The board of Jain Irrigation Systems has approved a plan to raise funds not exceeding ₹500 crore through a Qualified Institutional Placement (QIP).
• The capital raise is intended to fund the company's expansion plans.

Alembic Pharmaceuticals gets USFDA approval for generic acne cream

• Alembic Pharmaceuticals has received final approval from the U.S. Food & Drug Administration (USFDA) for its generic Tretinoin Cream.
• This medication is used for the topical treatment of acne vulgaris and is therapeutically equivalent to the reference drug, Retin-A Cream.

Punj Lloyd liquidation process extended by six months

• The National Company Law Tribunal (NCLT) has granted a six-month extension, until March 12, 2026, for the liquidation process of engineering firm Punj Lloyd.
• The extension was granted to support the completion of several critical ongoing national projects and to facilitate the potential sale of the company as a going concern to maximize value.

Zydus Lifesciences receives USFDA nod for angina and blood pressure tablets

• Zydus Lifesciences has secured final approval from the USFDA to market Diltiazem Hydrochloride tablets.
• These tablets are used for the management of chronic stable angina and angina due to coronary artery spasm.

Biocon's subsidiary obtains tentative USFDA approval for Rifaximin tablets

• Biocon Pharma Limited, a wholly-owned subsidiary of Biocon, has received tentative approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Rifaximin tablets.
• The drug will be manufactured in collaboration with Carnegie Pharmaceuticals LLC.

Caplin Point Laboratories' arm gets USFDA approval for heart failure drug

• Caplin Steriles Ltd, a subsidiary of Caplin Point Laboratories, received final USFDA approval for its generic milrinone lactate injection.
• This drug is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure.